Gene Query: NDUFS5

Dataset Description Geneva Score
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 42.94
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 39.6
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 38.7
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 38.7
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 35.83
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 34.77
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 34.44
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 34.44
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 33.73
NRDE2 negatively regulates nuclear exosome functions 32.43
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 31.23
Differentiation enhances Zika virus infection in neuronal brain cells 29.71
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 28.02
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 27.99
EP400 is required for Max and MCPyV mediated gene activation 27.2
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 26.16
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 24.79
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 23.86
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 23.86
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 23.25
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 23.25
RNA-Seq with and without RNase treatment in PCa cell lines 22.5
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 22.44
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 22.41
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 21.87
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 21.08
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 21.08
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 20.75
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 20.62
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 20.61
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 19.99
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 19.83
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 19.25
Mitochondrial dsRNA triggers antiviral signalling in humans 18.74
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 18.29
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 18.24
Developmental stage specific chromosome architecture in human erythroid cells 18.24
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 18.11
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 18.09
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 17.81
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 17.81
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 17.68
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 17.68
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 17.4
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 17.36
Role of microRNAs in the interaction between Salmonella and the host cell 17.31
Identification of transcription start sites for human A549 cell line using ReCappable-seq 17.26
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 16.92
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 16.68
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 16.64
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 16.48
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 16.44
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 16.44
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 16.27
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 16.19
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 16.05
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 16.05
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 15.95
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 15.83
Gene expression profiling of leukemia cells following asparagine depletion 15.82
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 15.72
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 15.55
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 15.51
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 15.32
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 15.27
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 15.26
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 15.09
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 15.05
EWSR1 influences alternative splicing through direct and indirect mechanisms 15.03
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 14.94
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 14.7
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 14.58
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 14.43
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 14.4
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 14.35
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 14.24
KLF6-dependent transcription in renal cancer cells 14.22
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 14.13
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 14.03
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 14.01
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 13.99
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 13.84
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 13.84
Systematic discovery of endogenous human ribonucleoprotein complexes 13.76
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 13.65
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 13.64
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 13.64
Tracking distinct RNA populations using efficient and reversible covalent chemistry 13.55
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 13.44
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 13.39
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 13.39
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 13.28
RNA m5C Methylation in breast cancer using MeRIP-Seq 13.18
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 13.15
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 13.11
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 13.1
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 13.1
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 13.09
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 12.93
Transcriptomic analysis of the HOTAIR-regulated genes 12.91
3’ Uridylation Expands miRNA Target Repertoire 12.83
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 12.81
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 12.81
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.72
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 12.71
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 12.66
Global analysis of enhancer targets: Mosaic-seq 12.57
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 12.48
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 12.46
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 12.42
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 12.22
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 12.22
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 12.15
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 12.15
Ribosomal footprinting of MDA-Parental and MDA-LM2 12.11
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 12.04
Identification of Atrial Fibrillation associated genes and functional non-coding variants 12.04
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 11.98
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 11.98
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 11.98
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 11.95
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 11.95
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 11.88
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 11.82
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 11.72
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 11.66
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 11.6
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 11.47
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 11.4
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 11.4
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 11.27
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 11.26
Effect of FGF13 depletion on the H460 cell line 11.2
CROP-Seq in Primary Human T Cells 11.19
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 11.17
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 11.16
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 11.12
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 11.1
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 11.02
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 10.92
Targeting EZH2 in MYCN-amplified Neuroblastoma 10.92
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 10.66
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 10.59
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 10.58
Genome-wide discovery of human splicing branchpoints [RNAse] 10.56
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 10.53
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 10.41
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 10.41
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 10.34
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 10.28
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 10.2
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 10.13
miR941 overexpression experiment 10.12
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 9.96
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 9.96
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 9.95
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 9.91
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 9.9
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 9.83
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 9.83
Identification of renal resident macrophages across species [C1] 9.79
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 9.78
Statins modulate endothelial transcriptional profile by inhibiting EZH2 9.77
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 9.77
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 9.77
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 9.71
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 9.7
Novel Targeting of Transcription and Metabolism in Glioblastoma 9.64
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 9.6
RNA editing in nascent RNA affects pre-mRNA splicing 9.6
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 9.6
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 9.57
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.48
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 9.48
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 9.45
IDH3a KO RNA-seq 9.44
Transcriptome analysis in Neobractatin treated cells 9.43
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 9.35
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 9.35
Integrin signaling regulates YAP/TAZ to control skin homeostasis 9.33
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 9.3
Total RNA-seq in ALL-SIL upon JQ1 inhibition 9.3
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 9.26
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 9.22
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 9.22
RNA sequencing of primary human platelets and in vitro cell lines 9.19
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 9.16
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 9.16
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 9.11
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 9.06
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 8.96
RNA-seq analysis of differentiating human erythroblasts 8.93
U1 snRNP telescripting regulates size-function stratified human genome 8.92
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 8.91
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 8.89
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 8.87
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 8.84
Human cells contain natural double-stranded RNAs with potential regulatory capacity 8.81
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 8.76
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 8.71
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 8.7
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 8.69
Global expression profiles in cardiac progenitor cells generated by ISX-9 8.67
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 8.67
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 8.63
Determining mRNA half-lives on a transcriptome-wide scale 8.61
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 8.55
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 8.54
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 8.51
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 8.49
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 8.49
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 8.47
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 8.47
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 8.38
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 8.36
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 8.34
Solid phase chemistry to covalently and reversibly capture thiolated RNA 8.27
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 8.24
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 8.24
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 8.21
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 8.18
Single-cell analysis of human kidney organoids 8.16
Identification of renal resident macrophages across species 8.15
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 8.04
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 7.98
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.91
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 7.88
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 7.86
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 7.79
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 7.75
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 7.75
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 7.72
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 7.62
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 7.62
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 7.6
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 7.54
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 7.44
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 7.42
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 7.35
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 7.3
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 7.29
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 7.29
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 7.26
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 7.26
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 7.26
Total RNA-seq in ALL-SIL upon TLX1 knockdown 7.15
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 7.13
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 7.1
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 7.07
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 6.99
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 6.96
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 6.89
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 6.88
Transcription control by the ENL YEATS domain in acute leukemia 6.85
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 6.85
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 6.85
Human HAP1 cells before and after nutrient deprivation 6.85
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 6.84
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 6.79
RNA-sequencing of healthy human skeletal myocytes 6.76
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 6.76
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 6.76
HEK293 Heat-shock experiment 6.76
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 6.72
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 6.67
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 6.65
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 6.65
LIN28A Over-expression RNAseq 6.64
Peptidomimetic blockade of MYB in acute myeloid leukemia 6.57
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 6.57
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 6.57
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 6.55
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  6.51
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 6.47
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 6.47
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 6.46
High-throughput sequencing of PROMPT-enriched samples. 6.38
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 6.35
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 6.32
Transcriptome analysis of kidney organoids 6.3
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 6.26
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 6.21
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 6.19
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 6.19
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.95
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 5.93
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 5.87
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 5.85
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 5.72
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.7
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.7
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.69
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 5.69
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.69
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.69
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 5.62
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.6
Trans-differentiation of human adult peripheral blood T cells into neurons 5.52
Microprocessor mediates transcription termination in long noncoding microRNA genes 5.43
A single-cell transcriptome atlas of the human pancreas 5.39
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 5.3
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 5.28
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 5.28
Next generation sequencing of small RNAs isolated from exosomes in human semen 5.27
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 5.23
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 5.23
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.2
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 5.17
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 5.17
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 5.16
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 5.12
Regulatory network controlling tumor-promoting inflammation in human cancers 5.12
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.09
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 5.06
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 5.06
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 5.04
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 5.0
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 5.0
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 4.97
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 4.97
Activity-dependent transcriptional changes in human neurons 4.96
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 4.94
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 4.89
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 4.81
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 4.81
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.79
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.77
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 4.76
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 4.74
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.73
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 4.65
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 4.65
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 4.64
Ribosome profiling upon inhibition of eIF4A 4.54
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.52
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 4.51
An siRNA screen identifies CHD4 as a target for epigenetic therapy 4.48
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 4.47
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 4.47
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 4.43
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 4.43
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 4.43
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 4.39
The effect of Abl kinases on non-small cell carcinoma global transcriptome 4.32
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 4.3
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 4.3
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 4.3
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 4.26
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.23
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 4.22
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.18
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 4.17
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 4.17
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 4.16
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 4.16
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 4.16
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.1
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.1
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.07
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.07
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.04
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.04
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 4.04
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 3.99
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 3.93
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 3.84
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 3.74
Iron response of HepG2 cells 3.74
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 3.72
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 3.71
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 3.68
oxLDL exposed trained monocytes 3.66
Transcriptomes of oxLDL exposed trained monocytes 3.66
p63 controls the enhancer landscape during keratinocyte differentiation 3.65
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 3.65
Positively selected enhancer elements endow tumor cells with metastatic competence 3.61
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.61
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 3.51
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 3.47
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 3.41
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.4
Electronic cigarettes 3.39
RNA seq with AML (NB4) cells upon FTO inhibition 3.38
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 3.37
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.33
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.33
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.3
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 3.28
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 3.24
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 3.24
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 3.09
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 3.01
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 3.0
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.99
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.99
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.92
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.88
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 2.86
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 2.8
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 2.73
NAPRT activation of macrophages 2.69
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 2.6
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 2.59
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.53
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 2.51
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.45
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 2.44
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 2.38
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 2.36
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 2.29
Induced DNA demethylation, genome instability and transcription 2.27
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.27
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.21
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.21
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 2.2
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 2.19
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.17
Dilated cardiomyopathy vs Myocarditis 2.13
Comparative Analysis of Cas9 Activators Across Multiple Species 2.12
Expression analysis of the TAF1 syndrome 2.1
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.09
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 2.07
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.04
Copper Regulation of HIF-1 Transcription Activity 2.04
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.97
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.89
RNAseq of cell lines with knocked in ESR1 mutations 1.83
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.8
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.79
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.79
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.75
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.69
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.67
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.67
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.67
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.62
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.59
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.58
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.54
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.5
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.5
Transcriptome analysis upon C6orf203 silencing 1.48
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.47
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.47
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 1.44
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.44
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.42
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 1.41
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.36
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.31
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.25
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.25
Global transcriptome analysis of WT versus HEB-/- hESCs 1.18
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.16
Differential gene expression in Jagged1 treated human dental pulp cells. 1.13
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.12
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.11
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.04
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.03
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.03
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.0
Transcriptional profiling of LS1034 cells treated with tepoxalin 0.99
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 0.94
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 0.86
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.81
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.81
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.8
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.79
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.76
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.71
Enhancer activation during EGF response 0.65
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.64
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.63
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.63
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.63
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.61
Expression profiling of MCF-7 cells with treatment of TCDD 0.61
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.58
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.57
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.57
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.56
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 0.53
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.42
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.37
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.36
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.34
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.27
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.26
siRNA-mediated knockdown 0.23
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.21
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.19
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.13
Metastasis in triple-negative breast cancer 0.13
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.08
Impact on erythroid progenitor type on erythroid differntiation 0.07
Gene expression profiling of KSHV-infected periodontal ligament cells 0.05
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.02
IMP3 regulated gene expression in breast cancer cells 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation